Ziad Al Nabhani, PhD
Assistant Professor, Universität Bern, Current Grantee
The Al Nabhani Lab studies how microbe-immune interplay during weaning influences lifelong host health. They are generating new therapies to treat autoimmunity, obesity, intestinal inflammation and neurodegenerative disorders.
Theresa Alenghat, VMD, PhD
Professor, Cincinnati Children’s Hospital Medical Center, Former Grantee
Dr. Alenghat’s lab investigates cell homeostasis in intestinal health and disease, searching for insight into pathways that mediate the host-microbiota relationship and how regulation affects innate immunity and chronic conditions like IBD.
Adebowale Bamidele, PhD
Assistant Professor, Mayo Clinic, Current Grantee
Dr. Bamidele is investigating metabolic mechanisms that reinvigorate the pathogenic functions of the adaptive immune system during IBD and how CD4 T cells perpetuate inflammation, with the therapeutic goal of restoring homeostatic balance.
Greg Barton, PhD
Professor; University of California, Berkeley; Former Grantee
Dr. Barton’s group studies innate immunity with the goal of understanding strategies of pathogen recognition and self/non-self discrimination to reveal critical balance points with fundamental implications for our understanding of immunity.
Andreas Bäumler, PhD
Distinguished Professor; University of California, Davis; Current Grantee
The Bäumler lab has pioneered the study of microbial physiology in its natural context of a host-associated microbial community. An overarching theme of their research is that the host plays a key role in shaping its gut microbiota to be beneficial.
Nicole Belle, MD, PhD
Assistant Professor, University of Pennsylvania, Current Grantee
Dr. Belle’s lab aims to unravel the mechanisms behind intestinal mucosal inflammation to elucidate the interactions between pathways and cells involved in intestinal mucosal damage and repair and apply them to the development of novel therapeutics.
